Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Functional Testing of Prefilled Syringes – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Functional Testing of Prefilled Syringes – V 2.0

Standard Operating Procedure for Functional Testing of Prefilled Syringes


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/165/2025
Supersedes SOP/SIM/165/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This Standard Operating Procedure (SOP) outlines the standardized process for performing functional testing of prefilled syringes used in sterile injectable manufacturing. Functional testing ensures that the syringe performs as intended without any mechanical failure during its intended use. The testing verifies usability, plunger movement,

syringe leakage, needle attachment, and injection force.

2. Scope

This SOP is applicable to all Quality Control (QC), Quality Assurance (QA), and Manufacturing departments involved in the inspection, testing, and release of prefilled syringes intended for sterile injectable use. It applies to both in-process samples and finished products.

3. Responsibilities

  • QC Analyst: Responsible for conducting the functional tests and recording observations accurately.
  • QA Officer: Verifies results and ensures compliance with specifications and procedural adherence.
  • Manufacturing Operator: Provides samples and information regarding production batches.
  • Head QC: Reviews and approves testing protocols and reports.
See also  Sterile Injectable Manufacturing: SOP for Troubleshooting Autoclave Issues in Sterilization - V 2.0

4. Accountability

The Head of Quality Control is accountable for ensuring that all functional testing of prefilled syringes is performed and documented in compliance with applicable procedures and standards.

5. Procedure

5.1 Sample Collection

  1. Collect representative samples from the beginning, middle, and end of each batch during or immediately after filling.
  2. Samples should be randomly selected to ensure unbiased testing.
  3. Record sample details in the Functional Testing Log (Annexure-1).

5.2 Equipment and Materials Required

  • Digital force gauge
  • Stopwatch
  • Leakage test apparatus
  • Micrometer or caliper (for dimensional checks)
  • Syringe holders and test fixtures
  • Safety gloves and protective gear

5.3 Functional Test Parameters

Each sample must undergo the following functional tests:

5.3.1 Plunger Functionality

  1. Inspect the syringe for smooth plunger movement from end to end.
  2. Pull the plunger rod completely and push back to confirm smooth motion and resistance.
  3. Reject syringes with jerky movement or resistance beyond 10% deviation from standard force.

5.3.2 Injection Force Measurement

  1. Place the syringe on the force gauge with the plunger aligned.
  2. Apply force slowly and record the peak force required to expel the solution.
  3. Injection force should not exceed 25 Newtons unless otherwise specified in product-specific guidelines.
See also  Quality Control: SOP for Conducting Repeat Testing in QC Labs - V 2.0

5.3.3 Leak Test

  1. Submerge the syringe in a water bath with an attached needle or cap.
  2. Apply internal pressure of 3 psi and hold for 30 seconds.
  3. Observe for any bubble formation indicating leakage.
  4. Reject syringes showing evidence of leaks.

5.3.4 Needle or Cap Attachment Integrity

  1. Test the strength of needle bonding or cap by applying a pull force.
  2. The attachment should withstand a pull force of 10 Newtons without detachment.

5.3.5 Visual and Dimensional Inspection

  1. Inspect each sample for visible cracks, air bubbles, overfilled or underfilled volumes.
  2. Measure the external diameter and length of the syringe barrel and plunger.
  3. Record deviations in the Dimensional Check Log (Annexure-2).

5.4 Documentation

  • Each test must be documented in real-time.
  • All observations, results, and analyst remarks must be recorded in the Functional Testing Report (Annexure-3).
  • Deviation or failure must be reported immediately to QA and documented through a deviation report.

5.5 Acceptance Criteria

  • All test parameters must meet specified limits for the lot to be considered acceptable.
  • If one or more units fail, perform investigation and re-sampling as per QA guidelines.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • psi: Pounds per Square Inch
  • Newton: Unit of force (N)
See also  Sterile Injectable Manufacturing: SOP for Analytical Method Development for Injectable Products - V 2.0

7. Documents

  1. Functional Testing Log – Annexure-1
  2. Dimensional Check Log – Annexure-2
  3. Functional Testing Report – Annexure-3

8. References

  • USP <1207> – Package Integrity Evaluation – Sterile Products
  • ISO 11040 – Prefilled Syringes Requirements
  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Functional Testing Log

Batch No. Sample ID Date Tested By Remarks
PFS-22001 SMP-05 20/06/2025 Ritika Desai Accepted

Annexure-2: Dimensional Check Log

Sample ID Barrel Diameter (mm) Plunger Length (mm) Deviation Status
SMP-05 12.05 85.00 Within Spec Pass

Annexure-3: Functional Testing Report

Sample ID Injection Force (N) Leak Test Plunger Test Needle Integrity Status
SMP-05 18.5 Pass Pass Pass Accepted

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New Process Introduction QA Head
24/06/2025 2.0 Added dimensional checks and leak test protocol Annual SOP Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: SOPs Not Aligned with Updated Annex 1 Requirements: A GMP Compliance Gap
Next Post: Biosimilars: SOP for Tangential Flow Filtration (TFF) Skid Operation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version